What's better than momentum? Mo' momentum.
Let's take a closer look at five of this past week's biggest scorchers.
|June 29||Weekly Gain||My Watchlist|
Supernus Pharmaceuticals soared after receiving welcome news from the Food & Drug Administration. The regulatory body has tentatively approved the central nervous system treatment specialist's Trokendi.
Entropic Communications was ready for prime time after the multimedia chip designer boosted its outlook for the current quarter.
Lincare Holdings was the picture of health after a Financial Times story reported buyout interest in the home medical equipment company from two potential bidders.
Quicksilver Resources was a gusher, even though Standard & Poor's downgraded the credit rating of the oil and gas explorer.
Unisys proves that the best offense is sometimes a good defense. The military contractor's stock moved higher after Unisys was awarded a homeland security contract that could be worth as much as $3 billion over the next few years to dozens of victorious companies (including Unisys, of course).
More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers, there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.
The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.